Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04634916 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

Study acronym: CONNECT-AV
StatusRecruiting
PhaseNot applicable
SponsorC. R. Bard
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 21% 280 → 220 participants
See other at-risk trials from C. R. Bard

Record History

  1. Enrollment reduced: 280 → 220 participantsv13
  2. Site contacts updated at 3 of 17 sitesv12
  3. Primary completion date: Jun 2026 to Jun 2027
    • Study sites: 14 to 17
    • Study completion date: Sep 2026 to Sep 2027
    v11
  4. Study sites: 12 to 14v10
  5. Primary completion date: Jun 2024 to Jun 2026
    • Study sites: 10 to 12
    • Study completion date: Sep 2024 to Sep 2026
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Site contacts updated at 1 of 10 sitesv8
  2. Study sites: 8 to 10v7
  3. Primary completion date: Mar 2023 to Jun 2024v6
  4. Study sites: 3 to 8v5
  5. Study sites: 1 to 3v4
  6. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 2021 to Mar 26, 2021
    v3
  7. Primary completion date: Jan 2023 to Mar 2023
    • Study completion date: Jul 2024 to Sep 2024
    • Start date: Jan 2021 to Mar 2021
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.
Trial Details
NCT Number NCT04634916
Lead Sponsor C. R. Bard
Conditions
(from sponsor)		 Kidney Disease, End-Stage, End-stage Renal Disease, Arteriovenous Fistula
Related terms Arteriovenous Fistula, Kidney Failure, Chronic
Enrollment 220 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov